Pharmaceutical compositions

Details for Australian Patent Application No. 2002213900 (hide)

Owner Novartis AG

Inventors Macerata, Richard; Huels, Jasper; Karabelas, Argeris Jerry; Khaled, Maha Y.; Gimona, Alberto; Jayawardene, Sumedha; Nic Lochlainn, Eimear Mairin; Holinej, Jurij; Sloan, Victor; Karnachi, Anees Abdulquadar; Bateman, Simon, David

Agent Davies Collison Cave

Pub. Number AU-B-2002213900

PCT Pub. Number WO02/20090

Priority 60/232,261 14.09.00 US; 60/231,655 11.09.00 US; Not Given 31.08.01 US

Filing date 10 September 2001

Wipo publication date 22 March 2002

Acceptance publication date 16 February 2006

International Classifications

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61K 31/196 (2006.01)

Event Publications

4 August 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Novartis Pharma GmbH to Novartis AG

16 February 2006 Application Accepted

  Published as AU-B-2002213900

16 March 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 09 Feb 2006. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street MELBOURNE VIC 3000

6 July 2006 Standard Patent Sealed

27 July 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Feb 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002213901

2002213899